STAT+: Pharmalittle: FTC suspends challenge to Amgen deal for Horizon; AstraZeneca is latest to challenge Medicare drug negotiations
Good morning, everyone, and nice to see you again after a week-long respite, during which…
Category: Pharma
STAT+: AstraZeneca sues to immediately stop Medicare drug price negotiation program
WASHINGTON — AstraZeneca is the sixth drug maker to pile on a legal challenge to…
STAT+: Weight loss drug Wegovy improves function in people with common type of heart failure
Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of…
STAT+: Pharmalittle: Mid-year price hikes for U.S. drugs reaches new heights; onetime biotech CEO Vivek Ramaswamy sparks debate at GOP debate
Good morning, Pharmalittle readers. Reporter Andrew Joseph here filling in for Ed from STAT’s London…
.jpg)
Mid-year drug price hikes are back despite Inflation Reduction Act
It’s almost a tradition. At the start and halfway points of each year, many pharmaceutical…
STAT+: Ron DeSantis wants to import drugs from Canada. Biden’s FDA just blasted his plan
WASHINGTON — Florida governor and presidential hopeful Ron DeSantis has ballyhooed a high-profile plan to…
STAT+: FDA approves Pfizer’s RSV vaccine for newborns; Boehringer sues over IRA
Good morning, one and all. Damian Garde here, filling in for Ed Silverman once more…
STAT+: Pharmalittle: Weight loss drugs cost much more in the U.S.; PBMs win a key victory over an Oklahoma law
And so, another working week will soon draw to a close. Not a moment too…
STAT+: ViiV Healthcare and Doctors Without Borders tussle over contract terms for an HIV drug
A feud has erupted between ViiV Healthcare and Doctors Without Borders over a deal to…
STAT+: U.S. appeals court strike down key provisions in Oklahoma law that regulates PBMs
A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate…
STAT+: Pharmalittle: U.S. appeals court upholds limits to abortion pill; ‘knock-off’ Ozempic thrives on ‘bogus’ website
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: South Africa ordered to disclose contracts with Pfizer, J&J, and other Covid-19 vaccine makers
A South African court ruled the government must disclose contracts signed with pharmaceutical companies for…
STAT+: In a rare move, FDA threatens to fine a company for failing to report clinical trial results
For only the fifth time, the U.S. Food and Drug Administration recently threatened to fine…
.jpg)
STAT+: Pharmalittle: Chinese drugmakers develop copycat weight loss drugs; SEC eyes supplier of research monkeys
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: FDA warns AstraZeneca over misleading promotional materials for a COPD drug
The U.S. Food and Drug Administration scolded AstraZeneca for making misleading claims about the effectiveness…
STAT+: SEC wants to know if key supplier of research monkeys bribed foreign officials
A U.S. government probe into a monkey-smuggling operation emanating from Cambodia has gone in a…
STAT+: Pharmalittle: Amazon Pharmacy offers insulin discounts; DOJ blasts industry attempt to delay Medicare drug-price talks
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
STAT+: BMS, looking to build a market for a heart drug, turns to a Viz.ai algorithm to detect disease
As Bristol Myers Squibb works to build its treatment for a heart condition that can…
STAT+: Pharmalittle: White House drug-shortage panel is MIA with lawmakers; Ultragenyx sued by Lacks family
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: More hospital pharmacists are rationing drugs due to increasing shortages
Nearly every hospital pharmacy across the U.S. is experiencing shortages of prescription drugs. And the…
STAT+: Pharmalittle: Supreme Court halts Purdue bankruptcy plan; what to know about compounded obesity drugs
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Supreme Court blocks Purdue bankruptcy plan that would shield Sacklers from lawsuits
The U.S. Supreme Court blocked a nationwide settlement with Purdue Pharma that was designed to…
STAT+: EPA fines Roche’s Genentech unit for hazardous waste violations
Following an extensive inspection, the U.S. Environmental Protection Agency fined Genentech more than $158,000 for…
STAT+: What to know about concerns raised about compounded versions of Novo Nordisk’s Wegovy
As demand for Ozempic and Wegovy surges, a little noticed warning about the medicines was…
STAT+: Pharmalittle: Genentech weighs delaying cancer therapy after drug pricing law; Novo continues to restrict supplies of low-dose Wegovy
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
STAT+: Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform
WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental…
STAT+: Pharmalittle: Wegovy heart study has docs seeing new possibilities; drugmakers file more ‘continuation’ patents that sideline generic rivals
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Opinion: Public pharma is the best solution to the ongoing problem of drug shortages
Drug shortages in the United States are at a record high. At least 14 essential…
Failed clinical trials don’t always spell doom for a new drug. Here’s why
This article was adapted from STAT’s latest report, “Failed trial, successful drug: how a negative…
STAT+: More drugmakers are filing continuation patents that sideline generic competition
Amid concerns that the pharmaceutical industry unfairly wins monopolies on medicines, a new analysis finds…
STAT+: Pharmalittle: Novo’s Wegovy obesity drug lowers cardiovascular risk in key trial; Nektar accuses Lilly of ‘misconduct’ in development deal
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: More regulation could be coming for drug ads
WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in…
STAT+: Nektar Therapeutics sues Lilly for ‘misconduct’ in drug development deal
A behind-the-scenes feud over a drug development program erupted into public view as Nektar Therapeutics…
STAT+: Pharmalittle: FDA OKs Sage drug for postpartum depression; major U.S. health systems to offer Alzheimer’s drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: White House drug-shortage task force brainstorms fixes; U.S. pharma layoffs are ballooning
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Vertex faces renewed calls to widen access to its cystic fibrosis medicines in poor countries
Several Latino advocacy groups and more than 100 clinicians from dozens of countries are lending…
STAT+: White House drug shortage task force held rare in-person meeting with industry
WASHINGTON — A new White House task force on drug shortages held a rare in-person…
STAT+: Pharmalittle: Patients brace for insurance decisions on weight loss drugs; Indian authorities find multiple problems at pharma plants
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
STAT+: Pharmalittle: Some employers cut insurance coverage for weight loss drugs; U.S. urges ADHD pill makers to boost production
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Intas Pharma employee used acid to destroy manufacturing records at troubled plant
Last November, an employee at Intas Pharmaceuticals, which makes several widely used chemotherapies that are…
STAT+: Pharmalittle: Medicare looks to improve Alzheimer’s care but sidesteps drug prices; CVS to cut 5,000 jobs
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
STAT+: Pharmalittle: House Republicans and Democrats duel over drug shortages; FDA approves second over-the-counter naloxone
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: New attacks on the drug industry would have made my breakthrough sickle cell treatment impossible
I was born in Alabama in the Jim Crow South, one of eight siblings in…
His book on the opioid crisis flopped in 2003. It now has a new life on Netflix
A new Netflix TV show about the origins and consequences of the opioid epidemic is…
STAT+: Pharmalittle: Pharma hopes reformulated drugs will skirt Medicare negotiations; Biogen to acquire Reata for $7.3 billion
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Policy experts call on Medicare to ensure data from Alzheimer’s drug registries is shared publicly
More than two dozen prominent health policy experts are urging the Biden administration to ensure…
STAT+: Pharmalittle: House Dems push new bill for Medicare drug negotiations; WHO leaves obesity drugs off essential medicines list
Top of the morning to you. And a steamy one, it is. In fact, there…
STAT+: How the first over-the-counter birth control pill in the U.S. got its ‘unapologetic’ design
It’s not every day that a marketing team is tasked with designing the branding and…
STAT+: European Commission accelerates phasing out animal testing, but stops short of a ban
After months of deliberation, the European Commission has agreed to accelerate the phasing out of…
STAT+: FDA inspection underscores problem at major U.S. compounder behind hospital drug recalls
One of the largest compound pharmacy operations in the U.S. recently recalled a slew of…